RAF INHIBITOR COMPOUNDS AND METHODS OF USE THEREOF
申请人:Aliagas Ignacio
公开号:US20130018033A1
公开(公告)日:2013-01-17
Compounds of Formula I are useful for inhibition of Raf kinases. Methods of using compounds of Formula I and stereoisomers, tautomers, prodrugs and pharmaceutically acceptable salts thereof, for in vitro, in situ, and in vivo diagnosis, prevention or treatment of such disorders in mammalian cells, or associated pathological conditions are disclosed.